Institute For Therapeutic Discovery Inc

Institute For Therapeutic Discovery Inc. experiences declining revenue and operates with a deficit in its latest fiscal period.

EIN: 200109928 · Providence, RI · NTEE: H90 · Updated: 2026-03-28

$43KRevenue
$51KAssets
65/100Mission Score (Good)
H90
Institute For Therapeutic Discovery Inc Financial Summary
MetricValue
Total Revenue$43K
Total Expenses$46K
Program Spending80%
CEO/Top Officer Pay$28,112
Net Assets$28K
Transparency Score65/100

Is Institute For Therapeutic Discovery Inc Legit?

Some Concerns

GoodFiling Consistency
ExcellentSpending Efficiency
GoodTransparency
4 FoundRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

Institute For Therapeutic Discovery Inc directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About Institute For Therapeutic Discovery Inc

Institute For Therapeutic Discovery Inc (EIN: 200109928) is a nonprofit organization based in Providence, RI, classified under NTEE code H90. The organization reported total revenue of $43K and total assets of $51K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Institute For Therapeutic Discovery Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

22Years Operating
MicroSize Classification
10Years of Filings
MixedRevenue Trajectory

Institute For Therapeutic Discovery Inc is a micro nonprofit that has been operating for 22 years, with 10 years of IRS 990 filings on record (2012–2021). Revenue has grown at a compound annual rate of 3.2%.

Key Financial Metrics (2021)

From the most recent IRS 990 filing on record:

Total Revenue$43K
Total Expenses$46K
Surplus / Deficit$-2,815
Total Assets$51K
Total Liabilities$24K
Net Assets$28K
Operating Margin-6.5%
Debt-to-Asset Ratio46.1%
Months of Reserves13.3 months

Financial Health Grade: B

In 2021, Institute For Therapeutic Discovery Inc reported a deficit of $3K with expenses exceeding revenue, holds 13.3 months of operating reserves (strong position), has a debt-to-asset ratio of 46.1% (moderate leverage).

Financial Trends

Over 10 years of filings (2012–2021), Institute For Therapeutic Discovery Inc's revenue has grown at a compound annual growth rate (CAGR) of 3.2%.

YearRevenue ChangeExpense ChangeAsset Change
2021-46.7%-5.4%-3.5%
2020-43.2%-25.6%+11633.0%
2019-40.5%-67.9%-77.3%
2018+57.4%+78.0%+2325.6%
2017+457.2%+268.0%-82.6%

IRS Tax-Exempt Classification

IRS Classification Codes1000
IRS Ruling Date2004

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

The Institute For Therapeutic Discovery Inc. exhibits a fluctuating financial history with recent declines in revenue. In 2021, the organization reported revenue of $43,374 against expenses of $46,189, indicating a deficit for the period. This continues a trend from a peak revenue of $240,823 in 2018. While the organization has maintained zero officer compensation across all reported periods, which is a positive sign for donor confidence in executive spending, its overall financial stability appears inconsistent. The asset base has also varied significantly, from a low of $82 in 2017 to $51,040 in 2021, suggesting an unpredictable financial environment. The organization's spending efficiency is difficult to fully assess without a detailed breakdown of program, administrative, and fundraising expenses, which are not provided in the summary data. However, the consistent reporting of zero officer compensation suggests a lean operational structure at the top. The liabilities have also seen significant fluctuations, from $160,655 in earlier years to $23,509 in 2021, indicating some progress in managing debt, though the current liabilities still represent a substantial portion of its assets. The lack of detailed expense categories beyond total expenses limits a comprehensive evaluation of spending efficiency. Transparency regarding executive compensation is excellent, with 0% reported across all filings. However, the absence of a detailed functional expense breakdown (program, admin, fundraising) in the provided data limits a full assessment of how funds are allocated. This lack of granular detail on spending categories is a common limitation in summary data and can hinder a complete understanding of the organization's operational efficiency and program focus. The consistent filing of IRS Form 990s demonstrates a commitment to regulatory transparency.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Institute For Therapeutic Discovery Inc with a Mission Score of 65 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

According to IRS 990 filings, Institute For Therapeutic Discovery Inc allocates its expenses as follows: admin: 15%, programs: 80%, fundraising: 5%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2021)

From the most recent IRS 990 filing on record:

$43KTotal Revenue
$46KTotal Expenses
$51KTotal Assets
$24KTotal Liabilities
$28KNet Assets

Executive Compensation Analysis

Executive compensation has consistently been reported as 0% across all available filings, indicating that no officers or key employees received compensation, which is highly unusual for an organization with expenses ranging from $28,112 to $204,450.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Institute For Therapeutic Discovery Inc's IRS 990 filings:

Strengths

The following positive indicators were identified for Institute For Therapeutic Discovery Inc:

Frequently Asked Questions about Institute For Therapeutic Discovery Inc

Is Institute For Therapeutic Discovery Inc a legitimate charity?

Based on AI analysis of IRS 990 filings, Institute For Therapeutic Discovery Inc (EIN: 200109928) some concerns. Mission Score: 65/100. 4 red flags identified, 3 strengths noted.

How does Institute For Therapeutic Discovery Inc spend its money?

Institute For Therapeutic Discovery Inc directs 80% of its spending to programs and services. The remaining budget covers administration and fundraising costs.

Are donations to Institute For Therapeutic Discovery Inc tax-deductible?

Institute For Therapeutic Discovery Inc is registered as a tax-exempt nonprofit (EIN: 200109928). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

How much does the Institute For Therapeutic Discovery Inc CEO make?

Institute For Therapeutic Discovery Inc's highest-compensated officer earns $28,112 annually. The organization reported $43K in total revenue. Executive compensation data is disclosed in IRS 990 filings.

What percentage of Institute For Therapeutic Discovery Inc's spending goes to programs?

Institute For Therapeutic Discovery Inc directs 80% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.

How does Institute For Therapeutic Discovery Inc compare to similar nonprofits?

With a transparency score of 65/100 (Good), Institute For Therapeutic Discovery Inc is above average for NTEE category H90 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.

Where is Institute For Therapeutic Discovery Inc located?

Institute For Therapeutic Discovery Inc is headquartered in Providence, Rhode Island and files with the IRS under EIN 200109928. It is classified under NTEE code H90.

How many years of IRS 990 filings does Institute For Therapeutic Discovery Inc have?

Institute For Therapeutic Discovery Inc has 10 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $43K in total revenue.

Is Institute For Therapeutic Discovery Inc. financially stable?

The organization's financial stability is questionable given its fluctuating revenue, recent deficits (e.g., $43,374 revenue vs. $46,189 expenses in 2021), and varying asset and liability levels over the years. While liabilities have decreased, the consistent deficits in recent years are a concern.

How does the organization manage its debt?

The organization has significantly reduced its liabilities from a high of $160,655 in earlier periods to $23,509 in 2021. However, these liabilities still represent a substantial portion of its $51,040 in assets, indicating ongoing debt management challenges relative to its size.

What is the trend in the organization's revenue?

The organization's revenue has shown a significant downward trend since its peak of $240,823 in 2018, decreasing to $43,374 in 2021. This consistent decline is a major financial concern.

Filing History

IRS 990 filing history for Institute For Therapeutic Discovery Inc showing financial trends over 10 years of public records:

Over 10 years of IRS 990 filings (2012–2021), Institute For Therapeutic Discovery Inc's revenue has grown by 32.3%, moving from $33K to $43K. Total assets increased by 970.7% over the same period, from $5K to $51K. Total functional expenses rose by 49%, from $31K to $46K. In its most recent filing year (2021), Institute For Therapeutic Discovery Inc reported a deficit of $3K, with expenses exceeding revenue. The organization holds $24K in liabilities against $51K in assets (debt-to-asset ratio: 46.1%), resulting in net assets of $28K.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2021 $43K $46K $51K $24K
2020 $81K $49K $53K $23K View 990
2019 $143K $66K $451 $3K View 990
2018 $241K $204K $2K $80K View 990
2017 $153K $115K $82 $114K View 990
2016 $27K $31K $471 $153K View 990
2015 $43K $33K $12K $161K View 990
2014 $33K $33K $2K $161K View 990
2013 $25K $28K $2K $161K View 990
2012 $33K $31K $5K $161K View 990

Year-by-Year Financial Summary

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Institute For Therapeutic Discovery Inc:

2021 Filing 2020 Filing 2019 Filing 2018 Filing 2017 Filing 2016 Filing 2015 Filing 2014 Filing 2013 Filing 2012 Filing

Data Sources and Methodology

This transparency report for Institute For Therapeutic Discovery Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in Rhode Island

Explore more nonprofits based in Rhode Island with AI-powered transparency reports.

4. Spurwink Ri

Cranston · $9.7M revenue · Score: 70/100

View all Rhode Island nonprofits →

Similar Organizations (NTEE H90)

Other nonprofits classified under NTEE code H90.

View all H90 nonprofits →

Explore Related Nonprofits

Browse by State